BMAC for Shoulder Arthritis: Could It Help Reduce Pain and Improve Function?

Shoulder arthritis can make everyday activities increasingly difficult, from reaching overhead and getting dressed to lifting objects or sleeping comfortably. As cartilage wears down and the joint becomes inflamed, pain and stiffness can interfere with mobility, strength, and quality of life. Although traditional treatments can help manage symptoms, some patients explore biologic procedures such as bone marrow aspirate concentrate (BMAC) as another option.

Could BMAC help reduce shoulder arthritis pain and improve function? BMAC is a treatment derived from a patient’s own bone marrow that contains a mixture of cells and biological signaling factors being studied for their potential role in musculoskeletal care. While it has attracted interest as a regenerative medicine approach, evidence supporting its effectiveness for shoulder osteoarthritis remains limited. Understanding how BMAC works, its potential benefits, and its limitations can help patients make informed decisions about treatment.

What Is BMAC and How Does It Work?

Bone marrow aspirate concentrate, or BMAC, is a biologic preparation made from bone marrow collected from the patient’s body, typically from the pelvic bone. The aspirated marrow is processed to concentrate certain cellular components, platelets, and other biological materials before being used in a medical procedure.

BMAC contains a heterogeneous mixture of cells, including a small population of mesenchymal stromal cells, along with growth factors and other signaling molecules. These components have been studied for their potential to influence inflammation, tissue repair processes, and the local joint environment.

In orthopedic medicine, BMAC is sometimes used in procedures intended to help manage joint pain and other musculoskeletal conditions. For shoulder arthritis, the preparation may be injected into the affected joint with the goal of reducing symptoms and improving function.

However, BMAC should not be considered a proven way to regenerate lost shoulder cartilage. Researchers are still investigating how its components affect osteoarthritis, and clinical outcomes can vary depending on the condition being treated, the preparation used, and the individual patient.

How Does Shoulder Arthritis Develop?

Shoulder arthritis occurs when the cartilage that normally cushions the joint gradually deteriorates. As the protective surface becomes thinner, the bones may experience greater friction and stress, contributing to pain, inflammation, and reduced movement.

The shoulder contains two primary joints: the glenohumeral joint, where the upper arm meets the shoulder blade, and the acromioclavicular joint, where the collarbone meets part of the shoulder blade. Osteoarthritis can affect either joint, although the glenohumeral joint is commonly associated with significant limitations in shoulder rotation and arm movement.

Common symptoms include:

• Shoulder pain that worsens with movement or activity.
• Stiffness, particularly when reaching overhead or behind the back.
• Reduced range of motion.
• Grinding, clicking, or a feeling of friction within the joint.
• Pain that interferes with sleep or daily activities.
• Difficulty lifting, carrying, or reaching for objects.

Shoulder arthritis may develop with age, following a previous injury, or because of long-term joint stress. Rotator cuff damage and other shoulder conditions can also contribute to joint degeneration. Identifying the underlying cause of pain is essential before considering a procedure such as BMAC.

Could BMAC Help Reduce Shoulder Arthritis Pain?

BMAC may offer symptom relief for some patients, but current evidence is insufficient to establish it as an effective treatment for shoulder osteoarthritis.

The rationale behind BMAC involves its potential biological effects. Certain cells and signaling molecules in the preparation may influence inflammatory activity and the joint’s local environment. Researchers are investigating whether these effects can translate into less pain and better physical function.

However, the presence of potentially beneficial cells does not guarantee a meaningful clinical improvement. BMAC preparations vary, and studies of cell-based treatments for osteoarthritis have used different processing methods, doses, and injection protocols.

Evidence specific to shoulder arthritis is particularly limited compared with the broader research on knee osteoarthritis. Results from knee studies cannot automatically be applied to the shoulder, which has different anatomy, movement demands, and patterns of degeneration.

Patients should therefore understand that BMAC is an emerging treatment option rather than an established solution for shoulder arthritis. It may be discussed in selected cases, but its benefits remain uncertain.

Can BMAC Restore Damaged Shoulder Cartilage?

BMAC is sometimes described as a regenerative treatment, but it is important to distinguish the treatment’s biological potential from proven cartilage regeneration.

Osteoarthritis involves structural changes within the joint, including the breakdown of cartilage and changes to the underlying bone. Once substantial cartilage has been lost, the joint may not return to its original condition simply because a biologic preparation is injected.

Although BMAC contains cells and signaling factors that may affect tissue responses, there is not enough high-quality clinical evidence to conclude that BMAC reliably rebuilds damaged cartilage in an arthritic shoulder. Patients should be cautious about claims that the procedure can reverse arthritis or eliminate the need for future surgery.

A more realistic discussion focuses on whether BMAC might reduce pain or improve movement for an individual patient, while acknowledging that these outcomes are not guaranteed.

Who Might Be a Candidate for BMAC for Shoulder Arthritis?

BMAC may be considered for certain patients with persistent shoulder pain who want to explore options beyond conventional symptom management. However, candidacy depends on the severity of arthritis, the patient’s overall health, the source of the pain, and the treatments already attempted.

A physician may evaluate several factors, including:

• Severity of joint degeneration: The extent of cartilage loss and other structural changes can influence which treatments are appropriate.
• Daily symptoms: Persistent pain, stiffness, and activity limitations help establish the impact of arthritis.
• Previous treatment: Physical therapy, activity modification, and other nonsurgical approaches may be considered before an injection procedure.
• Other shoulder conditions: Rotator cuff tears, instability, and other disorders may contribute to symptoms and require different treatment strategies.
• Treatment goals: A patient’s priorities, expectations, and willingness to accept uncertain outcomes are important to the decision.

BMAC may be less appropriate when severe joint damage requires a more definitive intervention. A thorough examination and appropriate imaging can help determine whether arthritis is the primary source of pain and whether a biologic procedure is reasonable to discuss.

What Happens During a BMAC Procedure for Shoulder Arthritis?

A BMAC procedure generally involves collecting bone marrow, processing it to concentrate selected components, and administering the preparation to the targeted area.

First, the physician identifies a suitable site for bone marrow collection, commonly the pelvic bone. After the area is cleaned and numbed, bone marrow is aspirated using a specialized needle. The sample is then processed, typically through centrifugation, to produce a concentrate.

The physician may use ultrasound or other imaging guidance to help direct an injection into the shoulder joint. The specific technique, anesthesia, and preparation protocol vary by provider and treatment setting.

Because BMAC requires a bone marrow aspiration as well as an injection, it is more involved than a routine joint injection. Potential risks include pain or bruising at the collection site, bleeding, infection, and temporary discomfort in the shoulder. The treating physician should explain the procedure’s risks, expected recovery, and any patient-specific concerns beforehand.

How Long Does Recovery Take After BMAC?

Recovery after BMAC varies according to the individual, the procedure used, and the condition of the shoulder. Patients may experience temporary soreness at the bone marrow collection site or in the treated joint.

Physicians may recommend temporarily limiting certain activities before gradually returning to normal movement. A rehabilitation plan may include guided exercises or physical therapy to help restore mobility and strength, depending on the patient’s needs.

There is no established recovery timeline that applies to everyone receiving BMAC for shoulder arthritis. Likewise, there is no guarantee that pain will improve or that any improvement will last. Because the evidence remains limited, patients should ask their physician what outcomes are realistic and how progress will be evaluated.

How Does BMAC Compare With Other Shoulder Arthritis Treatments?

BMAC is one of several approaches that may be discussed when shoulder arthritis causes persistent discomfort. Treatment selection should reflect symptom severity, functional limitations, overall health, and the degree of joint damage.

Common options include:

• Activity modification: Adjusting movements that aggravate symptoms may help reduce discomfort while preserving appropriate activity.
• Physical therapy: Targeted exercises can improve mobility, strengthen supporting muscles, and help maintain shoulder function.
• Medication: Depending on a patient’s health and medical history, medications may help manage pain and inflammation.
• Corticosteroid injections: These may provide temporary relief for some patients, although benefits vary and repeated injections require careful consideration.
• Shoulder replacement surgery: For advanced arthritis with substantial pain and disability, joint replacement may provide more predictable improvement than an unproven biologic procedure.

BMAC differs from these treatments because it uses a concentrated preparation derived from the patient’s own bone marrow. However, using a patient’s own biological material does not automatically make a treatment more effective or risk-free. There is currently insufficient evidence to establish BMAC as superior to standard treatments for shoulder osteoarthritis.

What Should Patients Ask Before Considering BMAC?

Before proceeding with BMAC, patients should ask their physician about the strength of the evidence, expected outcomes, costs, and available alternatives.

Useful questions include:

• What is causing my shoulder pain, and how advanced is my arthritis?
• What evidence supports BMAC specifically for shoulder osteoarthritis?
• What degree of pain relief or functional improvement is realistic?
• What are the risks associated with bone marrow collection and injection?
• Are established nonsurgical treatments or shoulder replacement more appropriate?
• What will the procedure cost, and will insurance cover any portion?

These questions can help patients distinguish evidence-based recommendations from claims that may overstate the benefits of regenerative medicine. Patients should also understand that coverage for BMAC varies and that they may need to pay out of pocket.

Is BMAC Worth Considering for Shoulder Arthritis?

BMAC may be worth discussing with a qualified orthopedic or pain management physician for selected patients seeking to understand all available options for shoulder arthritis. However, current research does not establish it as a reliably effective treatment for shoulder osteoarthritis, and it should not be presented as a proven method for rebuilding cartilage.

A careful evaluation can help identify the source and severity of shoulder pain, determine which treatments are appropriate, and establish realistic expectations. For many patients, physical therapy, activity modification, and other established treatments remain important parts of care. Those with advanced arthritis may benefit from discussing surgical options.

Ultimately, the goal is to reduce pain, preserve movement, and improve daily function through a treatment plan grounded in the best available evidence.